MedTrace Logo

Cerebral Prophylactic Irradiation With Saving Hippocampus and Amygdala

NCT03209128 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2022-06-23

No results posted yet for this study

Summary

Hippocampus and amygdala are parts of the brain involved in the recognition of emotions, memories, memory, language ... It is therefore very important to protect them during irradiation of the brain.

The aim of this study is to evaluate cerebral irradiation with saving hippocampus and amygdala protects these brain functions in patients with small cell lung cancer (SCLC) Radiotherapy of the brain

Conditions

  • Non Small Cell Lung Cancer

Interventions

RADIATION

Irradiation prophyllactique cérébrale

Irradiation prophyllactique cérébrale

Sponsors & Collaborators

  • Centre Francois Baclesse, Luxembourg

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2019-12-31
Completion
2021-03-19

Countries

  • Luxembourg

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03209128 on ClinicalTrials.gov